TP53 and neoplasm: In 1999, the Foster group searched a synthetic compound library for compounds that allowed mutant p53 to retain an active conformation and discovered CP-31398 (43) (Fig. 8), which restored transcriptional activity of the p21 gene in cells expressing mutant p53 and inhibited tumor growth in mice [54].